MedTrace Logo

Old Blood and Postoperative Complications

NCT02575820 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2016-05-13

No results posted yet for this study

Summary

The investigators sought to examine the effects of 'old' red blood cells on mortality and morbidity of patients who undergoing revision hip replacement arthroplasty. The investigators hypothesis is that patients have an increased risk of mortality and infection after 'old' red blood cells transfusions compared with those who received 'new' transfusions.

Conditions

  • Orthopedics
  • Postoperative Complications
  • Red Blood Cells

Interventions

PROCEDURE

Old red blood cells transfusion

Red blood cells (shelf life \> 14 days) transfusion during the operation (total hip replacement arthroplasty)

PROCEDURE

New red blood cells transfusion

Red blood cells (shelf life =\< 14 days) transfusion during the operation (total hip replacement arthroplasty)

Sponsors & Collaborators

  • Seoul National University Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-30
Primary Completion
2016-05-31
Completion
2016-05-31

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02575820 on ClinicalTrials.gov